Abpro Bio Co., Ltd. (KOSDAQ:195990)
South Korea
· Delayed Price · Currency is KRW 1,287.00
+37.00 (2.96%)
At close: Apr 29, 2026
Abpro Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -48,920 | -15,629 | -25,742 | -8,145 | -10,030 | Upgrade
|
| Depreciation & Amortization | 1,694 | 1,484 | 1,870 | 1,402 | 2,625 | Upgrade
|
| Loss (Gain) From Sale of Assets | 84.33 | -11,797 | 79.93 | -142.24 | -1,013 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4,640 | 2,191 | 254.14 | - | 748.73 | Upgrade
|
| Loss (Gain) From Sale of Investments | 2.93 | -7.36 | 3,238 | -2,218 | 3,950 | Upgrade
|
| Loss (Gain) on Equity Investments | 33,300 | 27,881 | 9,377 | -4,219 | 5,876 | Upgrade
|
| Stock-Based Compensation | 282.62 | - | - | - | 260.5 | Upgrade
|
| Provision & Write-off of Bad Debts | -134.33 | -3,782 | 195.08 | -17.77 | -1,209 | Upgrade
|
| Other Operating Activities | 1,224 | -9,327 | 3,750 | 6,387 | -3,969 | Upgrade
|
| Change in Accounts Receivable | 6,432 | 1,676 | 133.03 | -488.08 | 2,519 | Upgrade
|
| Change in Inventory | 159.29 | 4,461 | 4,677 | -3,553 | 1,461 | Upgrade
|
| Change in Accounts Payable | -4,915 | -1,190 | -996.65 | -1,347 | 567.74 | Upgrade
|
| Change in Income Taxes | - | - | - | - | 0.01 | Upgrade
|
| Change in Other Net Operating Assets | -535.29 | -1,713 | -1,698 | -119.35 | -4,005 | Upgrade
|
| Operating Cash Flow | -6,686 | -5,752 | -4,862 | -12,461 | -2,220 | Upgrade
|
| Capital Expenditures | -1,915 | -17,109 | -1,148 | -132.25 | -542.24 | Upgrade
|
| Sale of Property, Plant & Equipment | 124.7 | 28,932 | 60.11 | 5.18 | 53.1 | Upgrade
|
| Cash Acquisitions | - | -9,986 | -7,155 | - | - | Upgrade
|
| Divestitures | - | - | - | - | 1,606 | Upgrade
|
| Sale (Purchase) of Intangibles | -212.56 | 1,193 | -1,090 | 1,347 | -3,244 | Upgrade
|
| Investment in Securities | 5,530 | -8,198 | 16,416 | -14,012 | -161 | Upgrade
|
| Other Investing Activities | -36.26 | 2,442 | 134.18 | -7,663 | 4,846 | Upgrade
|
| Investing Cash Flow | 2,463 | -6,788 | 5,633 | -21,352 | 8,348 | Upgrade
|
| Short-Term Debt Issued | 748 | 5,593 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 17,240 | 6,900 | - | 14,616 | Upgrade
|
| Total Debt Issued | 748 | 22,833 | 6,900 | - | 14,616 | Upgrade
|
| Short-Term Debt Repaid | -1,443 | -5,677 | -150 | - | -56.83 | Upgrade
|
| Long-Term Debt Repaid | -6,676 | -8,582 | -5,572 | -3,373 | -236.25 | Upgrade
|
| Total Debt Repaid | -8,119 | -14,259 | -5,722 | -3,373 | -293.08 | Upgrade
|
| Net Debt Issued (Repaid) | -7,371 | 8,573 | 1,178 | -3,373 | 14,323 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 5,980 | Upgrade
|
| Other Financing Activities | -19.4 | -0 | -0 | - | - | Upgrade
|
| Financing Cash Flow | -7,391 | 8,573 | 1,178 | -3,373 | 20,303 | Upgrade
|
| Foreign Exchange Rate Adjustments | 19.03 | 604.41 | -44.09 | 177.25 | 688.93 | Upgrade
|
| Net Cash Flow | -11,595 | -3,362 | 1,905 | -37,009 | 27,120 | Upgrade
|
| Free Cash Flow | -8,601 | -22,861 | -6,011 | -12,593 | -2,762 | Upgrade
|
| Free Cash Flow Margin | -26.94% | -72.20% | -23.69% | -56.95% | -8.39% | Upgrade
|
| Free Cash Flow Per Share | -30.21 | -80.30 | -216.00 | -469.40 | -102.45 | Upgrade
|
| Cash Interest Paid | 987.68 | 628.37 | 417.18 | 397.92 | 400.65 | Upgrade
|
| Cash Income Tax Paid | -0.92 | -0.05 | 138.89 | -34.96 | 130.45 | Upgrade
|
| Levered Free Cash Flow | -7,144 | -19,266 | -6,703 | -6,719 | -12,719 | Upgrade
|
| Unlevered Free Cash Flow | -6,288 | -17,960 | -5,240 | -3,849 | -8,432 | Upgrade
|
| Change in Working Capital | 1,141 | 3,235 | 2,115 | -5,508 | 542.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.